Opinion|Videos|August 12, 2024
Clinical Factors Impacting Immunotherapy Response and Optimizing Patient Selection
A panel of experts on non-small cell lung cancer outline factors that impact how well patients respond to immunotherapy.
Advertisement
Video content above is prompted by the following questions:
- Outside of biomarkers, what clinical factors also lead to immune checkpoint inhibitor therapy underperformance?
- How can patient selection be optimized among those less likely to respond to immune checkpoint inhibitor therapy?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
FDA Clears First Single-Biomarker Blood Test for Alzheimer
3
New York Experts Push for Coordinated Obesity Care Teams
4
Grocery Assistance Benefit Linked to Fewer Diabetes Complications
5